Humanized and chimeric anti-factor C3 antibodies and uses thereof

• 收藏
• 分享

专利权人:

Novelmed Therapeutics; Inc

发明人:

Bansal, Rekha

申请号：

AU2013243574

公开号：

AU2013243574B2

申请日:

2013.04.02

申请国别(地区):

AU

年份:

2017

代理人:

摘要：

A method of inhibiting complement activation mediated by C3b inhibitors in a subject includes administering a C3b inhibitor to the subject to inhibit at least one of C3b binding to factors B and properdin, inhibit C3 cleavage, inhibit the activation of neutrophils, monocytes, platelets, and endothelium； or inhibit the formation of C3a, C5a, and MAC.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/